In this investing video, Champion Shares PRO portfolio manager Nathan Parmelee discusses GlaxoSmithKlines (LSE: GSK) decision to make its dividend payout the top priority and how that might lower its long-term growth potential.
Our top analysts have highlightedfive top shares in theFTSE 100in our special free report “5 Shares To Retire On“. To find out the names of the shares and the reasons behind their inclusion, simplyclick hereto view it immediately with no obligations whatsoever.
Nathan Parmelee has no position in any shares mentioned. The Motley Fool UK has recommended shares in GSK. We Fools don’t all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.
Nathan Parmelee has no position in any shares mentioned. The Motley Fool UK has recommended shares in GSK. We Fools don’t all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.
